93 related articles for article (PubMed ID: 25263389)
41. Ube2S regulates Wnt/β-catenin signaling and promotes the progression of non-small cell lung cancer.
Qin Y; Du J; Fan C
Int J Med Sci; 2020; 17(2):274-279. PubMed ID: 32038111
[TBL] [Abstract][Full Text] [Related]
42. p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells.
Mortazavi F; An J; Dubinett S; Rettig M
Mol Cancer Res; 2010 May; 8(5):762-74. PubMed ID: 20460685
[TBL] [Abstract][Full Text] [Related]
43. Abnormal expression and clinicopathologic significance of p120-catenin in lung cancer.
Wang EH; Liu Y; Xu HT; Dai SD; Liu N; Xie CY; Yuan XM
Histol Histopathol; 2006 Aug; 21(8):841-7. PubMed ID: 16691536
[TBL] [Abstract][Full Text] [Related]
44. Zbed3 Is Indispensable for Wnt Signaling Regulation of Cortical Layers Formation in Developing Brain.
Ruan X; Liu G; Zhou J; Chen P; Sun C; Liu W; Wu C; Hou L; Yin B; Qiang B; Shu P; Peng X
Cereb Cortex; 2021 Jul; 31(9):4078-4091. PubMed ID: 33822906
[TBL] [Abstract][Full Text] [Related]
45. TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer.
Liu L; Zhou XM; Yang FF; Miao Y; Yin Y; Hu XJ; Hou G; Wang QY; Kang J
Oncotarget; 2017 Sep; 8(37):62069-62080. PubMed ID: 28977927
[TBL] [Abstract][Full Text] [Related]
46. KIF3A binds to β-arrestin for suppressing Wnt/β-catenin signalling independently of primary cilia in lung cancer.
Kim M; Suh YA; Oh JH; Lee BR; Kim J; Jang SJ
Sci Rep; 2016 Sep; 6():32770. PubMed ID: 27596264
[TBL] [Abstract][Full Text] [Related]
47. c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells.
Mortazavi F; Dubinett S; Rettig M
Clin Exp Metastasis; 2011 Apr; 28(4):391-404. PubMed ID: 21336985
[TBL] [Abstract][Full Text] [Related]
48. Jinfu'an Decoction Inhibits Invasion and Metastasis in Human Lung Cancer Cells (H1650) via p120ctn-Mediated Induction and Kaiso.
Sun Z; Cao Y; Hu G; Zhao J; Chen M; Wang S; Ye Z; Chen H; Wang W; Wang Y
Med Sci Monit; 2018 May; 24():2878-2886. PubMed ID: 29735970
[TBL] [Abstract][Full Text] [Related]
49. Mechanism of Wnt/β-catenin signaling pathway in enhanced malignant phenotype of non-small cell lung cancer induced by anti-angiogenesis therapy.
Zhang XX; Zhang LL; Yang HL; Wang XW
Asian Pac J Trop Med; 2016 Jan; 9(1):58-62. PubMed ID: 26851788
[TBL] [Abstract][Full Text] [Related]
50. Co-expression of delta-catenin and RhoA is significantly associated with a malignant lung cancer phenotype.
Zhang D; Zhang JY; Dai SD; Liu SL; Liu Y; Tang N; Wang EH
Int J Clin Exp Pathol; 2014; 7(7):3724-32. PubMed ID: 25120748
[TBL] [Abstract][Full Text] [Related]
51. Beta-Catenin in Non-Small Cells Lung Cancer and Its Association with Proteasomes.
Kolegova ES; Shashova EE; Kostromitskii DN; Dobrodeev AY; Kondakova IV
Bull Exp Biol Med; 2020 Mar; 168(5):677-680. PubMed ID: 32246375
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA-CCAT2 promotes the occurrence of non-small cell lung cancer by regulating the Wnt/β-catenin signaling pathway.
Zhao C; Qiao C; Zong L; Chen Y
Oncol Lett; 2018 Oct; 16(4):4600-4606. PubMed ID: 30214594
[TBL] [Abstract][Full Text] [Related]
53. Dact3 inhibits the malignant phenotype of non-small cell lung cancer through downregulation of c-Myb.
Zhao H; Yang L; Han Y; Li H; Ling Z; Wang Y; Wang E; Wu G
Int J Clin Exp Pathol; 2017; 10(12):11580-11587. PubMed ID: 31966514
[TBL] [Abstract][Full Text] [Related]
54. Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues.
Fan CF; Miao Y; Lin XY; Zhang D; Wang EH
Tumour Biol; 2014 Jan; 35(1):765-71. PubMed ID: 23975372
[TBL] [Abstract][Full Text] [Related]
55. 14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer.
Zang D; Li X; Zhang L
Clin Exp Med; 2010 Dec; 10(4):221-8. PubMed ID: 20112043
[TBL] [Abstract][Full Text] [Related]
56. DISC1 overexpression promotes non-small cell lung cancer cell proliferation.
Wang S; Chen YY; Li YP; Gu J; Gu SD; Shi H; Li XS; Lu XN; Li X; Zhang SL; Yu KJ; Liu K; Ji LL
Oncotarget; 2017 Sep; 8(39):65199-65210. PubMed ID: 29029423
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of lumican accelerates lung cancer cell invasion through p120 catenin.
Yang CT; Li JM; Chu WK; Chow SE
Cell Death Dis; 2018 Apr; 9(4):414. PubMed ID: 29549325
[TBL] [Abstract][Full Text] [Related]
58. ASAP3 expression in non-small cell lung cancer: association with cancer development and patients' clinical outcome.
Fan C; Tian Y; Miao Y; Lin X; Zhang X; Jiang G; Luan L; Wang E
Tumour Biol; 2014 Feb; 35(2):1489-94. PubMed ID: 24078447
[TBL] [Abstract][Full Text] [Related]
59. Thyroid cancer 1 (C8orf4) shows high expression, no mutation and reduced methylation level in lung cancers, and its expression correlates with β-catenin and DNMT1 expression and poor prognosis.
Zheng YW; Zhang L; Wang Y; Chen SY; Lei L; Tang N; Yang DL; Bai LL; Zhang XP; Jiang GY; Yang LH; Xu HT; Li QC; Qiu XS; Wang EH
Oncotarget; 2017 Sep; 8(38):62880-62890. PubMed ID: 28968956
[TBL] [Abstract][Full Text] [Related]
60. GTPBP2 positively regulates the invasion, migration and proliferation of non-small cell lung cancer.
Jie L; Cong L; Conghui W; Ying G
J Cancer; 2021; 12(13):3819-3826. PubMed ID: 34093790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
